Here are the latest quarterly results of the stocks in the . For more detailed updates, check the latest stock quotes.
Click on title to sort | Sep 2021 | Sep 2022 | YoY %-Change | Get More Info | ||||
---|---|---|---|---|---|---|---|---|
Name | Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (%) |
PAT (%) |
P/E* (x) |
|
AUROBINDO PHARMA | 59,419 | 7,078 | 57,394 | 4,116 | -3.4% | -41.8% | 15.3 | More Info
|
AUROBINDO PHARMA | 59,419 | 7,078 | 57,394 | 4,116 | -3.4% | -41.8% | 15.3 | More Info
|
AUROBINDO PHARMA | 59,419 | 7,078 | 57,394 | 4,116 | -3.4% | -41.8% | 15.3 | More Info
|
AUROBINDO PHARMA | 59,419 | 7,078 | 57,394 | 4,116 | -3.4% | -41.8% | 15.3 | More Info
|
BIOCON | 18,404 | 2,103 | 23,197 | 1,101 | 26.0% | -47.6% | 29.4 | More Info
|
BIOCON | 18,404 | 2,103 | 23,197 | 1,101 | 26.0% | -47.6% | 29.4 | More Info
|
CIPLA | 55,198 | 7,120 | 58,285 | 7,978 | 5.6% | 12.0% | 15.2 | More Info
|
CIPLA | 55,198 | 7,120 | 58,285 | 7,978 | 5.6% | 12.0% | 15.2 | More Info
|
CIPLA | 55,198 | 7,120 | 58,285 | 7,978 | 5.6% | 12.0% | 15.2 | More Info
|
DIVIS LABORATORIES | 19,875 | 6,065 | 18,550 | 4,930 | -6.7% | -18.7% | 53.8 | More Info
|
DIVIS LABORATORIES | 19,875 | 6,065 | 18,550 | 4,930 | -6.7% | -18.7% | 53.8 | More Info
|
GLENMARK PHARMA | 31,474 | 2,748 | 33,752 | 2,787 | 7.2% | 1.4% | N.A. | More Info
|
LUPIN | 40,913 | -20,949 | 41,455 | 1,345 | 1.3% | N.A. | 18.4 | More Info
|
LUPIN | 40,913 | -20,949 | 41,455 | 1,345 | 1.3% | N.A. | 18.4 | More Info
|
LUPIN | 40,913 | -20,949 | 41,455 | 1,345 | 1.3% | N.A. | 18.4 | More Info
|
PIRAMAL ENTERPRISES | 15,737 | 2,943 | 18,937 | -17,085 | 20.3% | -680.5% | N.A. | More Info
|
SUN PHARMA | 96,259 | 20,887 | 109,523 | 22,602 | 13.8% | 8.2% | 13.0 | More Info
|
SUN PHARMA | 96,259 | 20,887 | 109,523 | 22,602 | 13.8% | 8.2% | 13.0 | More Info
|
ZYDUS LIFESCIENCES | 37,598 | 7,224 | 40,055 | 5,058 | 6.5% | -30.0% | 11.4 | More Info
|
ZYDUS LIFESCIENCES | 37,598 | 7,224 | 40,055 | 5,058 | 6.5% | -30.0% | 11.4 | More Info
|
Sector Aggregate | 917,495 | 65,073 | 964,136 | 97,514 | 5.1% | 49.9% | ||
* Trailing 12 months earnings, excluding extraordinary / exceptional items. |
Jun 2022 Results | Latest Quarter Results | View All Results |